JPMorgan Chase & Co’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-36
| Closed | – | – | 4986 |
|
|
2019
Q4 | $0 | Buy |
+36
| New | – | ﹤0.01% | 4982 |
|
|
2019
Q3 | – | Sell |
-727
| Closed | -$4K | – | 5010 |
|
|
2019
Q2 | $4K | Sell |
727
-1,142
| -61% | -$6.28K | ﹤0.01% | 4734 |
|
|
2019
Q1 | $6K | Sell |
1,869
-53,392
| -97% | -$171K | ﹤0.01% | 4701 |
|
|
2018
Q4 | $219K | Sell |
55,261
-42,246
| -43% | -$167K | ﹤0.01% | 3772 |
|
|
2018
Q3 | $1.93M | Buy |
97,507
+82,797
| +563% | +$1.64M | ﹤0.01% | 2807 |
|
|
2018
Q2 | $467K | Buy |
14,710
+14,054
| +2,142% | +$446K | ﹤0.01% | 3479 |
|
|
2018
Q1 | $25K | Buy |
656
+201
| +44% | +$7.66K | ﹤0.01% | 4365 |
|
|
2017
Q4 | $36K | Buy |
+455
| New | +$36K | ﹤0.01% | 4235 |
|